Joyvie Health Raises $1M to Redesign Continence Care

Jan de Vries · 2026-06-05

A UK-based startup is taking on a problem that affects hundreds of millions of people worldwide, yet has seen almost no innovation in decades. Joyvie Health just closed its pre-Seed round at $1.04 million to rethink continence underwear from the ground up. ### A Personal Tragedy Sparked This Mission Zoe Robson founded Joyvie Health after losing her father, Fred, to pancreatic cancer in 2025. Fred was 77, active, and sharp-minded when he received a late-stage diagnosis on Christmas Eve 2024. Eleven weeks later, he was gone. During those weeks, Fred lost bowel control and had to wear adult diapers. The problem? Standard products trap stool against the skin, causing breakdown, infections, and profound loss of dignity. Fred's skin deteriorated rapidly. His wife Ruth, the primary caregiver, carried an invisible burden that was crushing. "My parents didn't deserve that," Robson says. "They were both at their most vulnerable, and the product meant to help them was making it worse. The skin breakdown, the shame, the loss of dignity, the weight on my mum. It wasn't from lack of care. It's a design failure."  ### A Fresh Approach to an Old Problem Joyvie's solution is elegantly simple. Instead of trapping waste against the skin like traditional diapers, their underwear contains stool in a disposable pouch immediately after excretion. Early testing shows about 90% less stool-to-skin contact and changes that are roughly 70% faster. This matters because fecal incontinence affects an estimated 656 million people globally. Yet the most common non-invasive solution has barely changed for decades. Joyvie's design aims to maintain skin integrity, preserve dignity, and reduce the burden on caregivers. ### The Funding Behind the Vision The $1.04 million round combines an Innovate UK grant with investments from HERmesa Angels, SyndicateRoom, Lavender Ventures, and individual angel investors. Gail Armstrong from Lavender Ventures explains: "We back founders addressing large, underserved markets with innovative solutions that can meaningfully improve lives. The market is ripe for innovation, and Joyvie's approach has potential benefits for individuals, caregivers, healthcare systems, and the environment." ### 2026 HealthTech Funding Surge Joyvie's round sits within a broader wave of European HealthTech investment. Across the UK and Europe, related startups raised over $181 million in early 2026 alone. **Notable UK rounds include:** - Semble raised $36.2 million for its healthcare management platform - Evaro secured $21.9 million for NHS-licensed health services - JAAQ closed $15.6 million for enterprise partnerships - Calibre emerged with $2.9 million for health analytics - Nul raised $875,000 for alcohol-dependence care **European highlights:** - Recare in Berlin raised $38.6 million for AI hospital tools - Patronus secured $11.5 million for senior smartwatches - Tucuvi raised $17.7 million for voice-AI nursing automation - Ditto in Rotterdam raised $7.9 million for patient-friendly medical info - ShanX Medtech got $25 million for antimicrobial diagnostics - MedVasc raised $2.3 million for anesthesia catheters ### Why This Matters Now Faecal incontinence is often caused by aging, childbirth, surgery, or chronic illness. As populations age worldwide, the need for better solutions will only grow. Current products fail both patients and caregivers, creating physical harm and emotional trauma. Robson puts it bluntly: "Products designed for care should never cause harm. That's not a vision statement. It's the reason this company exists." Joyvie Health is still in early stages, but their approach offers a glimpse of what thoughtful design can achieve in a space that's been neglected for too long.